Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Solid Tumor × etoposide phosphate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neuroblastoma 3 Lymphoma, B-Cell 3 Ovarian Neoplasms 2 Medulloblastoma 2 Solid Tumor 1 Rhabdoid Tumor 1 Recurrence 1 Pyloric Stenosis, Hypertrophic 1 Pinealoma 1 Ovarian Germ Cell Cancer 1 Neuroectodermal Tumors, Primitive 1 Nervous System Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Lymphoproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Glioma 1 Ganglioneuroblastoma 1 Ependymoma 1 Diffuse Intrinsic Pontine Glioma 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1 Brain Diseases 1

Interventions

Injections 6 Fluorodeoxyglucose F18 4 Cyclophosphamide 4 Bevacizumab 4 toripalimab 2 fludarabine 2 Specimen Handling 2 Nivolumab 2 zimberelimab 1 tumor-cells apoptosis factor, human 1 trametinib 1 tislelizumab 1 temsirolimus 1 spartalizumab 1 pembrolizumab 1 pazopanib 1 palbociclib 1 olaparib 1 lenvatinib 1 etoposide phosphate 1 enzalutamide 1 envafolimab 1 donafenib 1 disitamab vedotin 1 dabrafenib 1 cemiplimab 1 avelumab 1 atezolizumab 1 anlotinib 1 WW Domain-Containing Oxidoreductase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04469530 2026-02-27

AflacST1903

Emory University

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡